DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$2.45 USD
+0.03 (1.24%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.45 0.00 (0.00%) 7:06 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, DiaMedica Therapeutics (DMAC) reported earnings of -$0.14 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for DMAC's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for DMAC
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services